A phase II study of mitomycin-C and S-1 as third-line chemotherapy in patients with advanced colorectal cancer

This study was conducted to evaluate the efficacy and safety of the combination of mitomycin-C (MMC) and S-1 as third-line chemotherapy for patients with advanced colorectal cancer (CRC) showing resistance to irinotecan- and oxaliplatin-containing regimens. Patients were recruited into the study fro...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: KIM, JUNG HAN, KIM, HYEONG SU, CHOI, DAE RO, JANG, GEUNDOO, KWON, JUNG HYE, KIM, HO YOUNG, JUNG, JOO YOUNG, KIM, HYO JUNG, SONG, HUN HO, SHIN, YUN HO, JUNG, SO YOUNG, KIM, BYUNG CHUN, ZANG, DAE YOUNG
Format: Artigo
Jezik:Inglês
Izdano: D.A. Spandidos 2011
Teme:
Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3406541/
https://ncbi.nlm.nih.gov/pubmed/22848297
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2011.367
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki